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The interaction of hemoglobin with phospholipid bilayer vesicles (liposomes) has been analyzed in several studies to better understand membrane–
protein interactions. However, not much is known on hemoglobin interactions with the aminophospholipids, predominantly localized in the inner leaflet of
erythrocytes, e.g., phosphatidylserine (PS), phosphatidylethanolamine (PE) in membranes containing phosphatidylcholine (PC). Effects of cholesterol,
largely abundant in erythrocytes, have also not been studied in great details in earlier studies. This work therefore describes the study of the interactions of
different hemoglobin variants HbA, HbE and HbF and the globin subunits of HbA with the two aminophospholipids in the presence and absence of
cholesterol. Absorption measurements indicate preferential oxidative interaction of HbE and alpha-globin subunit with unilamellar vesicles containing PE
and PS compared to normal HbA. Cholesterol was found to stabilize such oxidative interactions in membranes containing both the aminophospholipids.
HbE and alpha-globin subunits were also found to induce greater leakage of membrane entrapped carboxyfluorescein (CF) using fluorescence
measurements. HbE was found to induce fusion of membrane vesicles containing cholesterol and PE when observed under electron microscope. Taken
together, these findings might be helpful in understanding the oxidative stress-related mechanism(s) involved in the premature destruction of erythrocytes
in peripheral blood, implicated in the hemoglobin disorder, HbE/beta-thalassemia.
© 2007 Elsevier B.V. All rights reserved.Keywords: HbE variant; Globin subunit; Aminophospholipid; Hemoglobin autoxidation; Membrane fusion1. Introduction
Hemoglobin interaction of phospholipids of the erythrocyte
inner leaflet has been investigated earlier to understand the rela-
tionship between hemoglobin and the inner surface of the redAbbreviations: HbA, adult hemoglobin; HbF, fetal hemoglobin; PC,
phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine;
Chol, cholesterol; DMPC, dimyristoylphosphatidylcholine; DMPE, dimyris-
toylphosphatidylethanolamine; DMPS, dimyristoylphosphatidylserine; DOPC,
dioleoylphosphatidylcholine; DOPE, dioleoylphosphatidylethanolamine; CF,
6-carboxyfluorescein; SUV, small unilamellar vesicles; PMB, p-hydroxymercur-
ibenzoic acid sodium salt; S.E.M., standard error of the mean; TEM, transmission
electron microscopy
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doi:10.1016/j.bbamem.2007.08.019blood cell membrane [1–6]. The membrane effects induced by
hemoglobin interaction include the increase in osmotic fragility
[7], increase inmembrane permeability, inactivation ofmembrane-
bound enzymes and cross-linking of membrane constituents [8].
Shaklai and coworkers have demonstrated that the hemoglobin-
binding sites on the red blood cell membrane at pH 6 exhibit two
different affinities with binding constants differing from each other
by two orders of magnitude indicating both protein(s) and mem-
brane lipids to be involved [9]. The majority of binding was iden-
tified with an equilibrium dissociation constant, Kd of about
160 nM, while a small portion with a Kd of about 12 nM. Recent
studies have shown that phospholipid vesicles promote human
hemoglobin oxidation and such oxidative reactions have been
studied also with normal and abnormal hemoglobins in the
presence of phosphatidylserine (PS) vesicles [10–14].
Hemoglobin variants are abnormal forms of hemoglobin that
occur when changes (point mutations, deletions) in the globin
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protein. These changesmay affect the structure of the hemoglobin,
its behavior, its production rate, and/or its stability. Several
hundred hemoglobin variants have been documented, however,
only a few are common and clinically significant. The majority of
these are β-globin variants. Hemoglobin E is the most common
hemoglobin variants in the world. It is highly prevalent in South-
east Asia and is due to a mutation in the gene that creates the
β-globin (Glu26(B8)→Lys) chain. People homozygous for HbE
(have two copies of βE) have a mild hemolytic anemia, due to
premature removal of red blood cells from the circulation, mi-
crocytosis, and mild enlargement of the spleen. A single copy of
HbE does not cause symptoms unless it is combined with another
mutation, such as one for β-thalassemia trait. Hemoglobins A and
F are both tetramers made up of four polypeptide subunits: two
α-globin subunits and two β-like globin subunits, β-globin and
γ-globin respectively [15].
Most mammalian plasma membranes share an asymmetric
transbilayer distribution of phospholipids between the inner and
outer monolayer, a basic feature of normal cell operations [16].
Generally, PS and phosphatidylethanolamine (PE) are found
primarily in the inner leaflet while phosphatidylcholine (PC) and
sphingomyelin are found in the outer leaflet. Asymmetric distri-
bution of the aminophospholipids, PS and PE is recognized as very
important in vesicular trafficking, molecular recognition and cel-
lular sorting [17]. It has also been proposed that PE and PS are
exposed on the cell surface during early stages of apoptosis, re-
sulting in a total loss of aminophospholipid asymmetry in the
plasma membrane bilayer [18,19]. Erythrocyte membrane con-
tains larger amounts of 18% PE and 7% PS by weight in human
[20], those are almost exclusively localized in the inner leaflet.
Cholesterol is another highly abundant lipid in the human eryth-
rocyte membrane, 23% by weight, which has been shown to
protect against the changes induced by hemoglobin [21]. Most of
the earlier studies involving hemoglobin and membrane systems
were done with PS alone and little is known about the hemoglobin
interaction of PE and cholesterol. Moreover, there are not many
studies on the membrane interaction of hemoglobin variants HbE
andHbF in this respect. The present study describes the interaction
of hemoglobin variants HbA, HbE and HbF along with the globin
subunits of HbAwith PC-based phospholipid membranes contain-
ing PE and PS in the presence and absence of cholesterol. The
tailor-made small unilamellar vesicles (SUVs) have been used as
model membranes made of phospholipids with two different fatty
acyl chains ofmyristic (C14:0) and oleic acids (C18:1). DOPC and
DMPC favor the formation of lamellar bilayer organization with
N-methylated head groups. DMPE alone could form bilayer
however, DOPE, containing one double bond in the fatty acid
chains, does not favor bilayer organization [22,23].
Efforts have been made to study the effects of the aminopho-
spholipids,DMPS,DMPE andDOPEdoped inDMPC andDOPC
membranes in the presence and absence of cholesterol on the
autoxidation of hemoglobin/globin species using absorption
measurements, on the extent of leakage of entrapped CF by fluo-
rescence measurements and electron microscopic observation of
membrane vesicles upon treatment with HbE. Results indicated
preferential interactions of HbE over HbF and HbA and α-globinchain over that of the β-chain with membranes containing the
aminophospholipids, with PE imparting lesser effects than PS.
Cholesterol showed some kind of stabilizing effects in both in the
autoxidation and CF leakage.
2. Materials and methods
Critical considerations in the design of the experiments were to eliminate all
oxidants andmetal ions other than oxygen during the experiment. All glassware was
acid washed before use, and buffers were prepared with de-ionized water doubly
distilled on quartz. Finally, all buffers were filtered through 0.2-μm filter (Millipore).
All organic solvents used were of HPLC grade or freshly distilled.
2.1. Materials
DMPC,DMPE,DOPE, cholesterol andCFwere purchased fromSigma-Aldrich
Corporation (St. Louis, MO). DMPS and DOPC were from Avanti Polar Lipids
(Alabaster, AL). Cholesterol was re-crystallized from ethanol before use.
2.2. Methods
2.2.1. Isolation and purification of hemoglobin from human blood samples
Human blood samples taken for diagnosis from patients with hemoglobin
disorder were characterized by BioRad Variant HPLC system. The hemoglobin
variants, HbA,HbE andHbF,were characterized and estimated by theHPLC system
[24].Wehave purifiedHbA fromnormal individualswithHbA ranging from95% to
97%, HbE from homozygousHbE patients with HbE ranging from 90% to 92% and
HbF from patients withβ-major thalassemia with 91%HbF, respectively. The blood
samples were taken from patients at the time of diagnosis. Human erythrocytes, after
removal of the buffy coat and plasma, were extensively washed with phosphate-
buffered saline (5 mM phosphate, 0.15 M NaCl, pH 7.4). Hemoglobin was isolated
from packed erythrocytes by osmotic lysis using three volumes of 1 mM Tris, pH
8.0, at 4 °C for 1 h. The hemoglobin mixture was purified by gel filtration on
Sephadex G-100 column (30×1 cm) in a buffer containing 5mMTris, 50mMKCl,
pH 8.0. The hemoglobin samples were stored in oxy-form at −70 °C for less than
7 days and characterized by the measurements of absorption at 415 nm and 541 nm,
respectively. The purity of the hemoglobin preparations was checked by 15% SDS-
PAGE after staining with Coomassie blue. Densitometric analysis (Quantity One
software, BioRad USA) indicated the hemoglobin preparations to be N90% pure.
The protein concentration was determined spectrophotometrically using a molar
extinction coefficient of 125,000 M−1 cm−1 at 415 nm and 13,500 M−1 cm−1 at
541, nm respectively [25].
2.2.2. Preparation of human α- and β-globin subunits
The PMB derivatives of HbAwere prepared following the method of Bucci
and Fronticelli [26]. The α-PMB and β-PMB chains were separated by
following a method consisting of two-column selective ion-exchange
chromatography as described earlier [27]. To obtain α-PMB, the splitting
solution was equilibrated with 0.01 M phosphate buffer at pH 8.0 and passed
through a DEAE-cellulose column equilibrated and eluted with the same buffer.
To obtain β-PMB, the splitting solution was equilibrated with 0.01 M phosphate
buffer at pH 6.6 and applied on a CM-cellulose column, equilibrated and eluted
with the same buffer. The PMB was removed from the isolated α-PMB and
β-PMB chains by the addition of 50 mM 2-mercaptoethanol in 0.1 M phosphate
buffer, pH 7.5. The intact globin chain was purified from the mixture of globin
chains and unreacted PMB by gel filtration on a BioGel P2 column. Immediately
after separation, the subunits were dialyzed extensively against 0.1 M phosphate
buffer, pH 7.5 [28]. The concentrations of the subunits were measured by the
method of Lowry et al. [29]. The globin subunits were not stored for more than
48 h at 4 °C and characterized from their spectral characteristics to ascertain their
oxidative states.
Hemin (Sigma) was dissolved in a minimal volume of 0.1 N NaOH and diluted
with water to a final volume of 1 ml. The resulting solution was centrifuged at
15,000×g for 15min and the clear supernatant was used for experimentation. Hemin
was always freshly prepared and concentrations were determined spectrophotomet-
rically [30].
Table 1
The pseudo-first order rate constant (k in h−1) of the interaction of hemoglobin
variants and the globins chains of HbA with DMPC SUVs containing DMPS,
DMPE and cholesterol
Hemoglobin Membrane type
DMPC DMPC:
DMPE
DMPC:
DMPS
DMPC:
DMPS:Chol
HbA 0.03±0.005 0.067±0.008 0.55±0.09 0.583±0.11
HbE 0.13±0.03 0.477±0.135 0.923±0.22 0.79±0.16
HbF 0.116±0.01 0.293±0.07 0.85±0.17 0.78±0.08
α globin 0.16±0.04 1.04±0.2 1.49±0.32 1.27±0.26
β globin 0.133±0.02 0.74±0.13 1.105±0.2 0.82±0.18
Table 2
The pseudo-first order rate constant (k in h−1) of the interaction of hemoglobin
variants and the globins chains of HbAwith DOPC SUVs containing DOPE and
cholesterol
Hemoglobin Membrane type
DOPC DOPC:DOPE DOPC:Chol DOPC:DOPE:Chol
HbA 0.364±0.02 0.437±0.09 0.193±0.02 0.255±0.04
HbE 0.85±0.17 1.02±0.19 0.614±0.12 0.63±0.11
HbF 0.564±0.076 0.617±0.1 0.45±0.08 0.6±0.06
α Globin 1.01±0.18 1.24±0.25 0.675±0.12 0.874±0.2
β Globin 0.666±0.13 0.97±0.22 0.392±0.07 0.644±0.16
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The required amount of phospholipid was dissolved in chloroform and the
phospholipid film was deposited by removing the solvent under a slow stream of
nitrogen and further dried for overnight under high vacuum. The lipid film was
finally hydrated with the required buffer and vortexed to disperse the lipids. The
dispersion was sonicated for 20 cycles (1-min burst with 10-s interval) maintaining
the temperature around 4 °C using a probe sonicator (dr.hielscher, GmbH,UP 200 s).
Following probe sonication, SUVs were centrifuged at 12,000×g for 15 min to
remove titanium and lipid aggregate. Then the liposomes were allowed to stand for
30 min at ∼25 °C and used within 6 h of preparation [31].
Phospholipid SUVs of various compositions were used in the experiments
described. We have used the following compositions with the mole percent of the
particular lipid given in the parenthesis, e.g., DMPC (100), DMPC/DMPE (80:20),
DMPC/DMPS (80:20), DMPC/DMPS/Chol (70:20:10) and DOPC (100), DOPC/
DOPE (90:10), DOPC/Chol (90:10) and DOPC/DOPE/Chol (85:10:5).
2.2.4. Study of autoxidation of hemoglobin and its derivatives in the presence of
phospholipid SUVs
The interaction of hemoglobin variants (HbA, HbE, and HbF) and purified
globin subunits (both α-globin and β-globin) with SUVs of different phospholipid
compositions were studied by monitoring the changes in characteristic absorption
spectral properties of hemoglobin and its derivatives.
All experiments were performed with hemoglobin variants mainly in the oxy-
form (HbA, HbE, HbF), globin subunits (both α- and β-globin), and SUVmixtures
at a phospholipid to hemoglobin molar ratio of 100 with 250 μM phospholipid
monomers interacting with 2.5 μM of tetrameric hemoglobin or equivalent globin
subunit (10μMper heme). The reactionmixture containing 20mMHEPES, 10mM
NaCl, pH 7.0, was incubated at 37 °C and the absorption spectra (250–700 nm)
recorded every 15 min for about 2 h. This phospholipids to hemoglobin ratio was
chosen at a value so that oxidation occurred in a time period that could be measured
reliably by spectrometric methods [10] using a double beam absorption
spectrophotometer (Aquarius 7000 series, CeCil Instruments Limited, UK).
Spectral changes from 500 to 700 nm were followed to monitor the loss of oxy-
hemoglobin species and generation of met-hemoglobin and hemichrome indicating
the interaction between hemoglobin species and the phospholipid components [11].
The determinations of the concentrations of the different oxidized hemoglobin
species were done by using a four-component analysis method elaborated before
[32]. At definite time intervals absorption spectra were recorded, from which the
concentrations of oxy-hemoglobin were calculated following the equations below
(Eq. (1)). Care was taken so that no precipitation occurred during the reaction time
due to formation of choleglobin.
½oxy Hb ¼ 119 A577  39 A630  89 A560: ð1Þ
To compare the extent of loss of oxy-Hb of different species in the presence
of phospholipid membranes, percent of oxy-Hb remaining at a specific time
interval was calculated as follows:
oxy

Hbð%Þ ¼ f½oxy Hbt=½oxy

Hb0g  100 ð2Þ
where [oxy-Hb]t is the concentration of oxy-Hb at time ‘t’ in the presence of the
membrane SUVs and [oxy-Hb]0 is the initial oxy-Hb concentration at time
t=0 min, before the addition of the membrane SUVs.The pseudo-first-order rate constant (k) were obtained from the slopes of the
linear fit of the logarithmic values of concentrations of oxy-hemoglobin vs. time
(t) plot for the initial disappearance of the oxy-hemoglobin, from two
independent experiments, elaborated in the earlier reports [11]. Errors in the
rate constants quoted in Tables 1 and 2 were estimated from the uncertainties in
the individual rate constant values emerging from the fitted process. Comparison
of the k-values was done to estimate the rate of induced oxidation of hemoglobin
species in the presence of different type of phospholipid components.
2.2.5. Preparation of CF entrapped SUVs for leakage experiment
The interaction of hemoglobin and its derivatives with phospholipids SUVswas
also studied by measuring the extent of release of SUV entrapped self-quenching
dye, 6-CF. SUVs containing 6-CF at its self-quenching concentration were prepared
by the method of probe sonication [33–35].
Concentration of 6-CF was determined spectrophotometrically at 492 nm using
molar extinction coefficient of 72,000. The phospholipid film was hydrated in
HEPES buffer (20 mM HEPES, 10 mM NaCl, pH 7.0) containing 30 mM 6-CF
(used as self-quenching concentration). The liposomes entrapped with 6-CF were
separated from the free dye by gel permeation on SephadexG-50. TheCF-entrapped
SUVs were collected in the void volume and were used immediately for further
experimentation within 2 h [35].
The SUVs of different phospholipid composition were treated with hemoglobin
samples at a phospholipid to hemoglobinmolar ratio of 100 at pH7.0 and 37 °C. Each
experimental set consisted of 500 μM of phospholipid monomers interacting with
5 μMof hemoglobin or globin subunit or hemoglobin sample (20 μMwith respect to
heme) in the same HEPES buffer and was incubated for 60 min at 37 °C before
measuring the fluorescence intensity a in a Jobin-Yvon (Horiba, USA) fluorescence
spectrophotometer. The CF fluorescence intensity increased more than 30-fold when
treatedwith 0.1% (w/v)TritonX-100whichwas taken as 100% leakage [34,35]. In all
CF leakage experiments, hemin was used as a positive control and BSA as a control
for non-heme protein. The error bars associatedwith the percentage of CF leakage are
the mean CF leakage (%) with standard error of mean (S.E.M.), presented as mean±
S.E.M. values from four independent experiments for each membrane systems and
were further subjected to the two-tailed Student's t-test. The changes in the extent of
CF leakage (%) values were found to be statistically significant with Pb0.05.
2.2.6. TEM study of the phospholipids SUVs treated with HbE
DOPC SUVs containing DOPE and cholesterol have been used for TEM
(Hitachi H-600 operating at 75 kV) studies after treatment with HbE. Themixture of
hemoglobin (5 μM) and the phospholipids SUVs (500 μM) was incubated at 37 °C
for 30 min and was placed on formver/carbon-coated copper grids and was nega-
tively stained with 2% phosphotungstic acid for TEM observation. The sizes of the
phospholipid vesicles were analyzed counting more than 50 SUVs of different
DOPC-based membranes and the diameter was expressed as mean±S.E.M.
3. Results
3.1. Study of autoxidation of hemoglobin species by absorption
spectroscopy
The relative extent of formation of various hemoglobin oxi-
dation products and loss of oxy-hemoglobin concentration has
Fig. 1. Absorption spectra of (A) HbA (N95% in oxy-form); (B) HbF (N95% in
oxy-form) and (C) HbE (N90% in oxy-form) in the presence of DMPC/DMPS
SUVs at two different time intervals, in the absence (bold lines) and 15 min after
the addition of the SUVs at 37 °C. Inset shows the same spectra in the
wavelength range of 500–700 nm showing the new peak at 630 nm.
Fig. 2. Plot of percentage of oxy-form of different hemoglobin species (oxy-Hb%)
at different time intervals: (A) oxy-Hb (%) in the presence of DMPC SUVs and
(B) in the presence of DOPC SUVs.
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hemoglobin and globin subunits in the presence of phospholipid
SUVs. The representative absorption spectra of HbA, HbF and
HbE in the presence of DMPC/DMPSSUVs have been shown just
before the addition of the SUVs and after 15-min incubation at37 °C, shown in Fig. 1, from which the oxy-hemoglobin concen-
tration was evaluated (Eq. (1)). We have observed decrease in the
absorbance at 415 nm and an increase in absorbance at 630 nm
indicative of the formation of met-hemoglobin species in the
presence of the membrane SUVs [21].
Fig. 2 shows the decrease in oxy-hemoglobin concentration
with time for HbA, HbE, HbF and the two globins chains in the
presence of DMPC (Fig. 2A) andDOPC (Fig. 2B) SUVs. The rate
of decrease was different depending on the hemoglobin variant or
the globin subunits used. Faster rate of disappearance of oxy-
hemoglobin was seen for HbE over HbA and α-chain over β-
chain. HbF also showed greater oxidative membrane interaction
compared to HbA. Both the globin subunits reacted to a much
greater extent compared to the intact HbA.With DOPC SUVs, the
extent of decrease in total oxy-hemoglobin concentration, com-
parable for both α-globin and HbE, has been much larger com-
pared to DMPC (Fig. 2B). The hemoglobin preparations, used in
the present work were not at the level of all chains 100% oxy-
genated. The ratio of absorbance at 415 nm to the same at 541 nm
was used as the yardstick for hemoglobin in oxy-form (Fig. 1) for
Fig. 3. Plot of percentage of oxy-Hb form of different hemoglobin species at
different time intervals: (A) oxy-Hb (%) in the presence of DMPC/DMPS SUVs
(filled symbols, solid line) and DMPC/DMPS SUVs containing cholesterol (empty
symbols, dotted line) and (B) in the presence of DOPC/DOPE SUVs (filled
symbols, solid line) and DOPC/DOPE SUVs containing cholesterol (empty
symbols, dotted line).
Fig. 4. Histogram representation of the extent of CF leakage induced by HbA, HbE
(both in oxy- and cyano-met form), HbF, α-globin and β-globin chains, hemin and
BSA in different (A) DMPC- and (B) DOPC-based membrane systems.
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HbF (90–98%) were in the oxy-form before undergoing
autoxidation in the presence of either of the DMPC and DOPC
membranes. More than 90%HbE and both the globin chains were
in oxy-formwhile experimenting in the presence of DMPC SUVs.
However, the extent of HbE and the globin chains in oxy-formwas
about 80%, as reflected in the values at zero time in the presence of
DOPC SUVs (Fig. 2).
Presence of 10–20% DMPS in DMPC SUVs showed faster
rate and greater oxidativemembrane interaction of the hemoglobin
species again showing preference for α-globin and HbE (Fig. 3A).
In all cases the extent of decrease in oxy-hemoglobin concentration
was much greater than in pure DMPC membranes. However,
cholesterol showed a distinct inhibitory or stabilizing effect when
present in DMPC/DMPS membranes and both the HbE variant
and α-globin subunit became substantially stabilized in the
presence of cholesterol. The extent of loss of oxy-hemoglobin
for HbE remained almost unchanged in DOPC SUVs containing
DOPE. However, for globin subunits, the percent loss of oxy-hemoglobin is much greater in the presence of DOPE compared to
control DOPC. Presence of cholesterol showed similar stabilizing
effects and inhibited the formation of oxidized products of
hemoglobin, e.g., met-hemoglobin (Fig. 3B) compared to pure
DOPC or DOPC/DOPE membranes. The pseudo-first-order rate
constant of the decrease in concentration of oxy-hemoglobin
species has been summarized in Table 1 for DMPC-based
membrane systems and Table 2 for the DOPCmembrane systems.
3.2. Study of release of 6-CF from phospholipid SUVs
The ability of different hemoglobin variants to interact with the
phospholipid SUVs has been measured in terms of the extent of
leakage of CF entrapped in the vesicle.
The extent of leakage was found to depend on type of he-
moglobin species used and the phospholipid composition of the
SUVs used. Different hemoglobin variants showed differential
Table 3
Diameter (Å) of the TEM characterized phospholipid SUVs
Hemoglobin SUV system used
DOPC (Å) DOPC:Chol (Å) DOPC:DOPE (Å)
Control 350±60 450±70 490±80
HbE 1100±100 N1500 1600±100
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based phospholipid systems in combination with DMPE, DMPS
and cholesterol. The extent of CF leakage was 14% with HbA,
which increased up to 31% with HbE in pure DMPC SUVs. This
effect is more pronounced in DMPC SUVs containing the
aminophospholipids, DMPE and DMPS. The extent of leakage
increased to 15.5% for HbA and to 33.1% for HbE in the presence
of DMPE and to 24.3% and 41.3% for HbA and HbE respectively
in the presence of DMPS. Presence of 10% cholesterol in DMPC/
DMPS SUVs prevented the release of CF to a considerable extent
reducing the HbE induced leakage to 34% from 41% in the
absence of cholesterol. HbF followed a similar trend with that of
HbE inducing 32% leakage of CF from DMPC SUVs (Fig. 4A).
The α-globin subunit induced the largest extent of 55% CF
leakage from SUVs of DMPC/DMPS compared to both the
DMPC andDMPC/DMPESUVswhich is decreased to 46% in the
presence of cholesterol. The effect of β-globin was not so pro-
nounced and was comparable with that of HbA. By examining
variousmembrane systems containing aminophospholipids, it was
observed that effect HbE was stronger with DMPC/DMPEFig. 5. Transmission electron micrographs of (A) DOPC SUVs; (B) DOPC SUVs trea
The bars represent 1000 Å.membranes compared to the α-globin chain. On the other hand,
the effect of α-globin was stronger than both HbE and HbAwith
DMPC/DMPS membranes. Cholesterol, however, stabilized both
the membrane systems towards all the hemoglobin species, HbE
and the α-globin chains in particular. The CF leakage data also
clearly indicate stronger effects of HbE in DOPC/DOPE SUVs
inducing 36% leakage compared to 22.5% by HbA (Fig. 4B).
Hemin alone induced 30–40% leakage of CF from almost all types
of membranes showing about 60% leakage particularly from
DMPC/DMPS SUVs. However, BSA on the other hand induced
not more than 5% leakage. Fig. 4 summarizes all CF leakage data
in both the DMPC- and DOPC-based membrane systems in com-
bination with the aminophospholipids in the presence and absence
of cholesterol. The HbE both in its oxy-form and in its cyano-met
form, purified from hemolysates of HbE/β-thalassemia patients,
perturbed the phospholipids membrane to a comparable extent
(Fig. 4).
3.3. TEM observation of HbE-treated DOPC SUVs
DOPC SUVs were subjected to TEM studies indicating large
increase in the size of the phospholipid vesicles both in the pres-
ence and absence of DOPE and cholesterol upon treatment with
HbE. Table 3 summarizes the sizes of the DOPC SUVs containing
cholesterol and DOPE in the presence and absence of HbE. The
size of DOPC SUVs with a mean vesicle diameter of 350 Å
(Fig. 5A) increased to 1100 Å in the presence of HbE (Fig. 5B).
The size of DOPC SUVs containing 10% cholesterol, with meanted with HbE; (C) DOPC/Chol SUVs; (D) DOPC/Chol SUVs treated with HbE.
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presence of HbE (Fig. 5D). Similar increase was also seen in the
size of DOPC SUVs containing 10% DOPE, with mean vesicle
diameter of 490 Å increased to N1600 Å in the presence of HbE
(not shown). The TEM studies indicated fusion of phospholipid
SUVs in the presence of HbE. The effects of HbAon the size of the
vesicles weremarginal, however, hemin induced similar fusogenic
effects on the phospholipids membranes (not shown).
4. Discussion
The oxidative interaction between hemoglobin and the cell
membrane is thought to be an important factor in the senescence of
red blood cells and also in various hemolytic disorders [36].
Experimental evidence indicated lipid peroxidation and other
oxidative membrane alterations or changes in adult hemoglobin as
factors responsible for hemolysis. However, such studies on mem-
brane interactions have not been done with abnormal hemoglo-
bins, particularly for HbE which is associated with an important
class of anemia, HbE/β-thalassemia. We have studied the oxi-
dative interaction of HbE along with HbA and HbF with DOPC
and DMPC-based membranes containing aminophospholipids
with and without cholesterol. Membrane interactions of hemoglo-
bin variantswere enhanced in the presence of aminophospholipids,
e.g., the bilayer forming DOPE in DOPC membranes and DMPS
in DMPC membranes. Presence of cholesterol in membranes
containing the aminophospholipids decreased the extent of
membrane perturbation by all the hemoglobin species used in
the present work. Recent studies have indicated influences of the
phospholipids head groups, surface charge, asymmetric distribu-
tion and the presence of cholesterol to affect the phospholipid
peroxidation [37–40]. Membrane cholesterol has been found to
have regulatory effects on the aminophospholipid asymmetry in
oxidized erythrocytes [41]. The susceptibility of cells to oxidative
stress is dependent on the nature and physical state of the mem-
brane lipid bilayer. Cholesterol directly modulates the physical
properties of lipid bilayers, altering membrane responses to de-
generative process, including lipid peroxidation [42].
The pseudo-first-order rate constant of the decrease in
concentration of oxy-hemoglobin species for DMPC-based mem-
brane systems with higher phase transition temperatures indicated
that in pure DMPC membranes the oxidation rate increased sub-
stantially from0.03 h−1 forHbA to 0.13 h−1 forHbE and0.116 h−1
for HbF. The hemoglobin preparations used in the present study are
N90% pure. However, there could be other redox proteins, e.g., the
peroxiredoxins present in the hemoglobin preparations as minor
contaminants which could also affect the autoxidation rates. In the
presence of 20% DMPE in DMPC, the rate constants were
enhanced by 2-fold while about 20-fold in the presence of 20%
DMPS in DMPC showing autoxidation of HbA to be favored by
the aminophospholipids. Cholesterol, however, decreased the rate
constants in all of them. Both the globin subunits showed con-
siderably enhanced oxidation rate with 0.162 h−1 for α-globin and
0.133 h−1 forβ-globin compared to 0.03 h−1 for HbA (Table 1). In
the DOPC membrane systems, with substantially lower phase
transition temperatures, containing DOPE and cholesterol, the rate
constant values were increased considerably compared to those inDMPCmembrane systems (Table 2). Presence of HbE favored the
oxidation to a large extent, specifically in the presence of DOPC
containing unsaturated fatty acyl chains. Also, the presence of
aminophospholipids favored the interaction to a larger extent
showing significant increase in the rate constants, particularly in the
presence of DMPS. Presence of cholesterol in the membrane
containing aminophospholipids, however, showed stabilizing
effects inhibiting the oxidation process also shown earlier to
protect against the changes of hemoglobin [21]. In all DMPC- and
DOPC-based membranes, the magnitude of the rate constants was
found to increase in HbE over HbA and in α-chain over β-chain
(Tables 1 and 2).
Differential effects of HbE and α-globin chains were also
revealed from experiments on the CF release from membrane
vesicles. An earlier study has indicated that the rate of increase
of erythrocyte lipid monolayer surface pressure upon autoxida-
tion of different hemoglobin variants followed the order:
HbENHbFNHbSNHbA and the ability of various hemoglobins
to affect lipid peroxidation in the RBC membrane also followed
the same order [43]. Autoxidation of different hemoglobin variants
in the presentwork followed the order:α-globinNHbE∼HbFNβ-
globinNHbA in interacting with tailor-made phospholipid SUVs.
The CF leakage data also follow a similar trend with phospholipid
SUVs. The possible faster rate of heme release could be accounted
for greater membrane-mediated autoxidation of HbE as observed
in HbS [43,44]. Among the globin subunits, α-globin induced the
largest changes in phospholipid SUVs compared to the β-globin
subunit or HbA. It has been earlier shown that entrapment of
purified α-globin chains within normal erythrocyte significantly
enhanced cellular oxidant stress and resulted in changes of thal-
assemic cells [45]. Previous work on oxidative hemoglobin
denaturation by phosphatidylserine liposomes pointed out that
oxidation is conditioned by pre-association of hemoglobinwith the
phospholipid and is dominated by electrostatic forces [46]. Various
studies have indicated that the oxidative interaction between
hemoglobin and phospholipid occurs via two steps involving both
electrostatic as well as hydrophobic interaction, although their
relative contributions to the different secondary changes in the
protein and the membrane are substantially different. The binding
and intrusion of the heme appear to be due mainly to hydrophobic
interactions [21]. The released hemin intercalates into the core of
the lipid bilayer and also triggers a Fenton-like reaction simul-
taneously [10,43].
In this study we have used relatively low concentration
(2.5 μM) of hemoglobin variants, also used in many other studies
on the interaction of hemoglobin with phospholipid membrane
vesicles [10,11,46]. It has been earlier shown that at low Hb
concentrations, Hb tetramers dissociate to dimers, which exhibit a
much higher rate of heme dissociation than the tetramers [47].
Consequently, Hb autoxidation was enhanced by dissociation into
dimers [48]. However, it has also been clearly established that at
3 μM Hb tetramer concentration, increased oxidation of Hb was
not observed on further decreasingHb concentration and indicated
that the enhanced oxidation of hemoglobin in the presence of
phospholipid membrane vesicles is not directly related to the
concentrations of oxy-Hb tetramers and dimers and remained
linear for about 50 h [11].
8 P. Datta et al. / Biochimica et Biophysica Acta 1778 (2008) 1–9The protecting effect of cholesterol has been explained in terms
of tighter packing of fatty acyl chains in the presence of cholesterol
presenting a steric barrier to the access of hemoglobin and/or heme
detached from globin to lipid hydroperoxides [14]. This protecting
effect of cholesterol might play a crucial role in maintaining the
stability of the inner leaflet of cell membrane when hemoglobin
comes in constant contact with the negatively charged PS-rich
bilayer and the degree of stabilization is the highest with phos-
pholipids carrying saturated fatty acyl chains. This study also
indicates preferential interactions of HbE and theα-globin subunit
of HbA with DMPC/DMPS membranes, in particular and in
DMPC/DMPE and DOPC/DOPEmembranes all of them forming
phospholipid bilayers with phase transition temperatures remain-
ing within 24–29 °C [49]. The TEM observation of the membrane
vesicles upon treatment with HbE showed large fused membrane
structures indicating better fusogenic potential of HbE compared
to HbA as observed in HbS at physiological pH and ionic strength
conditions [50]. To explain such differential interaction ofHbE and
α-globin with respect to others, the differential degree of de-
tachment of heme from the protein counterpart might be one of the
key reasons. From our crystal structure studies on the HbE it has
been shown that the surface charge distribution in HbE is sig-
nificantly different from that of HbA also indicating the origin of
its thermal instability and the heme binding property compared to
HbA [51]. Free hemin has been found to induce larger extent of CF
leakage from membrane SUVs (Fig. 4) also indicating that HbE
could be more susceptible to heme release particularly under
oxidative stress and may play a role in the pathophysiology of
HbE/β-thalassemia. It has been shown earlier that HbE could
release heme faster than HbA upon oxidation [43]. Oxidative
denaturation of sickle hemoglobin induced by PS pointed out such
oxidations to be conditioned by the pre-association of hemoglobin
with the phospholipids and is dominated by electrostatic forces
[46,11]. Also an earlier study confirmed stronger affinity of α-
globin chains for cell surface lipids and proteins compared to HbA
and/orβ-globin chains [52]. Taken together, these results might be
helpful in understanding the oxidative stress-relatedmechanism(s)
involved in explaining the premature destruction of erythrocytes in
thalassemia, and in particular, HbE/β-thalassemia.
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